Immunovant, Inc. IMVT Interest Expense
Interest Expense at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:InterestIncomeExpenseNonoperatingNet.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s interest expense?
- Immunovant, Inc. (IMVT) reported interest expense of $8.06M in Q1 2026.
- How has Immunovant, Inc.'s interest expense changed year-over-year?
- Immunovant, Inc.'s interest expense increased by 17.0% year-over-year, from $6.89M to $8.06M.
- What is the long-term trend for Immunovant, Inc.'s interest expense?
- Over 3 years (2023 to 2026), Immunovant, Inc.'s interest expense has grown at a 49.5% compound annual growth rate (CAGR), from $7.58M to $25.33M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.